Literature DB >> 19847640

In vitro fertilisation (IVF) with donor eggs in post-menopausal women: are there differences in pregnancy outcomes in women with premature ovarian failure (POF) compared with women with physiological age-related menopause?

Devini Ameratunga1, Gareth Weston, Tiki Osianlis, James Catt, Beverley Vollenhoven.   

Abstract

PURPOSE: This study assessed pregnancy rates and obstetric outcomes in women with premature ovarian failure (Group A) with post-menopausal women > or =40 years (Group B) who had IVF +/- ICSI using donor eggs.
METHODS: This was a retrospective analysis of 54 recipients with either premature ovarian failure or physiological menopause undergoing oocyte donation between 2000 and 2007 at Monash IVF.
RESULTS: The average number of stimulated cycles required for a woman in group A and B to deliver a baby was 1.75 and 1.4 respectively. Both groups had high cumulative pregnancy rates; however, there was a statistically significant difference with regards to rates of complications.
CONCLUSION: Oocyte donation in both premature ovarian failure and physiological menopause is highly successful and cumulative pregnancy rate is an important statistic which can be used to inform women seeking this technique. High rates of complications, in conjunction with individual risk-factor analysis needs to be considered when counselling post-menopausal women about oocyte donation.

Entities:  

Mesh:

Year:  2009        PMID: 19847640      PMCID: PMC2788687          DOI: 10.1007/s10815-009-9351-5

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  17 in total

1.  Increased risk of pregnancy-induced hypertension in young recipients of donated oocytes.

Authors:  Debbra A Keegan; Lewis C Krey; Hung-Chi Chang; Nicole Noyes
Journal:  Fertil Steril       Date:  2007-01-29       Impact factor: 7.329

2.  Cumulative conception and live birth rates after oocyte donation: implications regarding endometrial receptivity.

Authors:  R J Paulson; I E Hatch; R A Lobo; M V Sauer
Journal:  Hum Reprod       Date:  1997-04       Impact factor: 6.918

3.  Premature gonadal failure.

Authors:  C B Coulam
Journal:  Fertil Steril       Date:  1982-12       Impact factor: 7.329

4.  Oocyte donation to women of advanced reproductive age: pregnancy results and obstetrical outcomes in patients 45 years and older.

Authors:  M V Sauer; R J Paulson; R A Lobo
Journal:  Hum Reprod       Date:  1996-11       Impact factor: 6.918

5.  Improvements achieved in an oocyte donation program over a 10-year period: sequential increase in implantation and pregnancy rates and decrease in high-order multiple pregnancies.

Authors:  Erdal Budak; Nicolas Garrido; Sergio Reis Soares; Marco Antonio Barreto Melo; Marcos Meseguer; Antonio Pellicer; José Remohí
Journal:  Fertil Steril       Date:  2007-02-28       Impact factor: 7.329

6.  Pregnancy outcome after age 50.

Authors:  Michal J Simchen; Yoav Yinon; Orit Moran; Eyal Schiff; Eyal Sivan
Journal:  Obstet Gynecol       Date:  2006-11       Impact factor: 7.661

7.  Screening for FOXL2 gene mutations in women with premature ovarian failure: an Indian experience.

Authors:  Suparna Chatterjee; Deepak Modi; Anurupa Maitra; Seema Kadam; Zarine Patel; Jyotsna Gokrall; Pervin Meherji
Journal:  Reprod Biomed Online       Date:  2007-11       Impact factor: 3.828

Review 8.  Oocyte and embryo donation 2006: reviewing two decades of innovation and controversy.

Authors:  Mark V Sauer; Suzanne M Kavic
Journal:  Reprod Biomed Online       Date:  2006-02       Impact factor: 3.828

9.  Pregnancy in women 50 or more years of age: outcomes of 22 consecutively established pregnancies from oocyte donation.

Authors:  M V Sauer; R J Paulson; R A Lobo
Journal:  Fertil Steril       Date:  1995-07       Impact factor: 7.329

10.  The evolution and outcome of pregnancies from oocyte donation.

Authors:  G Pados; M Camus; A Van Steirteghem; M Bonduelle; P Devroey
Journal:  Hum Reprod       Date:  1994-03       Impact factor: 6.918

View more
  8 in total

1.  Oocyte donation: a risk factor for pregnancy-induced hypertension: a meta-analysis and case series.

Authors:  Ulrich Pecks; Nicolai Maass; Joseph Neulen
Journal:  Dtsch Arztebl Int       Date:  2011-01-21       Impact factor: 5.594

2.  Novel methods of treating ovarian infertility in older and POF women, testicular infertility, and other human functional diseases.

Authors:  Antonin Bukovsky
Journal:  Reprod Biol Endocrinol       Date:  2015-02-25       Impact factor: 5.211

3.  Uterine transplantation in transgender women.

Authors:  B P Jones; N J Williams; S Saso; M-Y Thum; I Quiroga; J Yazbek; S Wilkinson; S Ghaem-Maghami; P Thomas; J R Smith
Journal:  BJOG       Date:  2018-09-20       Impact factor: 6.531

4.  Fibroinflammatory Signatures Increase with Age in the Human Ovary and Follicular Fluid.

Authors:  Jordan H Machlin; Seth J Barishansky; John Kelsh; Megan J Larmore; Brian W Johnson; Michele T Pritchard; Mary Ellen Pavone; Francesca E Duncan
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

Review 5.  Premature ovarian insufficiency: the context of long-term effects.

Authors:  A Podfigurna-Stopa; A Czyzyk; M Grymowicz; R Smolarczyk; K Katulski; K Czajkowski; B Meczekalski
Journal:  J Endocrinol Invest       Date:  2016-04-18       Impact factor: 4.256

Review 6.  Advanced maternal age: ethical and medical considerations for assisted reproductive technology.

Authors:  Brittany J Harrison; Tara N Hilton; Raphaël N Rivière; Zachary M Ferraro; Raywat Deonandan; Mark C Walker
Journal:  Int J Womens Health       Date:  2017-08-16

Review 7.  Reproduction in premature ovarian insufficiency patients - from latest studies to therapeutic approach.

Authors:  Błażej Męczekalski; Marzena Maciejewska-Jeske; Agnieszka Podfigurna
Journal:  Prz Menopauzalny       Date:  2018-09-30

8.  Establishment of Effective Mouse Model of Premature Ovarian Failure Considering Treatment Duration of Anticancer Drugs and Natural Recovery Time.

Authors:  Eun Hee Lee; Si Eun Han; Min Jung Park; Hyeon Jung Kim; Hwi Gon Kim; Chang Woon Kim; Bo Sun Joo; Kyu Sup Lee
Journal:  J Menopausal Med       Date:  2018-12-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.